Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals With Opioid Use Disorder

Over 10 million individuals pass through U.S. detention centers on an annual basis, with nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy, treatment with medications for opioid use disorder (MOUD) is underutilized in jail settings—a gap that could be addressed us...

Descripción completa

Detalles Bibliográficos
Autores principales: Belcher, Annabelle M., Coble, Kelly, Cole, Thomas O., Welsh, Christopher J., Whitney, Anna, Weintraub, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585441/
https://www.ncbi.nlm.nih.gov/pubmed/34777036
http://dx.doi.org/10.3389/fpsyt.2021.703685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585441/
https://www.ncbi.nlm.nih.gov/pubmed/34777036
http://dx.doi.org/10.3389/fpsyt.2021.703685

Ejemplares similares